8-KThe WireRoutine
Shareholder Vote
Filed Jun 16, 2021 · 5y ago · Accession 0001171843-21-004375
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Jun 16, 2021
- Report date
- Jun 15, 2021
- Document
- f8k_061621.htm
- Size
- 196 KB